These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


649 related items for PubMed ID: 31534043

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. The Golgi apparatus acts as a platform for TBK1 activation after viral RNA sensing.
    Pourcelot M, Zemirli N, Silva Da Costa L, Loyant R, Garcin D, Vitour D, Munitic I, Vazquez A, Arnoult D.
    BMC Biol; 2016 Aug 18; 14():69. PubMed ID: 27538435
    [Abstract] [Full Text] [Related]

  • 43. The PINK1-PARKIN Mitochondrial Ubiquitylation Pathway Drives a Program of OPTN/NDP52 Recruitment and TBK1 Activation to Promote Mitophagy.
    Heo JM, Ordureau A, Paulo JA, Rinehart J, Harper JW.
    Mol Cell; 2015 Oct 01; 60(1):7-20. PubMed ID: 26365381
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Negative regulation of the RLH signaling by the E3 ubiquitin ligase RNF114.
    Lin B, Ke Q, Li H, Pheifer NS, Velliquette DC, Leaman DW.
    Cytokine; 2017 Nov 01; 99():186-193. PubMed ID: 28625874
    [Abstract] [Full Text] [Related]

  • 47. Lck/Hck/Fgr-Mediated Tyrosine Phosphorylation Negatively Regulates TBK1 to Restrain Innate Antiviral Responses.
    Liu S, Chen S, Li X, Wu S, Zhang Q, Jin Q, Hu L, Zhou R, Yu Z, Meng F, Wang S, Huang Y, Ye S, Shen L, Xia Z, Zou J, Feng XH, Xu P.
    Cell Host Microbe; 2017 Jun 14; 21(6):754-768.e5. PubMed ID: 28618271
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Viral hijacking of cellular ubiquitination pathways as an anti-innate immunity strategy.
    Chen M, Gerlier D.
    Viral Immunol; 2006 Jun 14; 19(3):349-62. PubMed ID: 16987055
    [Abstract] [Full Text] [Related]

  • 51. Peroxiredoxin 1 Interacts with TBK1/IKKε and Negatively Regulates Pseudorabies Virus Propagation by Promoting Innate Immunity.
    Lv L, Bai J, Gao Y, Jin L, Wang X, Cao M, Liu X, Jiang P.
    J Virol; 2021 Sep 09; 95(19):e0092321. PubMed ID: 34260286
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. β-arrestin1 is an E3 ubiquitin ligase adaptor for substrate linear polyubiquitination.
    McElrath CJ, Benzow S, Zhuo Y, Marchese A.
    J Biol Chem; 2023 Dec 09; 299(12):105474. PubMed ID: 37981209
    [Abstract] [Full Text] [Related]

  • 54. Ubiquitin E3 ligase MID1 inhibits the innate immune response by ubiquitinating IRF3.
    Chen X, Xu Y, Tu W, Huang F, Zuo Y, Zhang HG, Jin L, Feng Q, Ren T, He J, Miao Y, Yuan Y, Zhao Q, Liu J, Zhang R, Zhu L, Qian F, Zhu C, Zheng H, Wang J.
    Immunology; 2021 Jul 09; 163(3):278-292. PubMed ID: 33513265
    [Abstract] [Full Text] [Related]

  • 55. Ubiquitin-Conjugating Enzyme 2S Enhances Viral Replication by Inhibiting Type I IFN Production through Recruiting USP15 to Deubiquitinate TBK1.
    Huang L, Liu H, Zhang K, Meng Q, Hu L, Zhang Y, Xiang Z, Li J, Yang Y, Chen Y, Cui S, Tang H, Pei H, Bu Z, Weng C.
    Cell Rep; 2020 Aug 18; 32(7):108044. PubMed ID: 32814047
    [Abstract] [Full Text] [Related]

  • 56. Amyloid Precursor Protein (APP) May Act as a Substrate and a Recognition Unit for CRL4CRBN and Stub1 E3 Ligases Facilitating Ubiquitination of Proteins Involved in Presynaptic Functions and Neurodegeneration.
    Del Prete D, Rice RC, Rajadhyaksha AM, D'Adamio L.
    J Biol Chem; 2016 Aug 12; 291(33):17209-27. PubMed ID: 27325702
    [Abstract] [Full Text] [Related]

  • 57. Ubiquitin conjugating enzyme E2-N and sequestosome-1 (p62) are components of the ubiquitination process mediated by the malin-laforin E3-ubiquitin ligase complex.
    Sánchez-Martín P, Romá-Mateo C, Viana R, Sanz P.
    Int J Biochem Cell Biol; 2015 Dec 12; 69():204-14. PubMed ID: 26546463
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 33.